Coronavirus Infections: all 952 studies
Page 10 of 10. Open to participants first (50), then studies with results posted, then the rest; newest registration first within each.
- Adverse Events Related to Treatments Used Against Coronavirus Disease 2019CompletedNCT04314817
- The Observational Study of Cardiac and Pulmonary Ultrasound and Evaluation of Treatment of Severe Patients With Novel Coronavirus PneumoniaStatus unknownNCT04314271
- Mechanisms for Covid-19 Disease ComplicationsStatus unknownNCT04314232
- Development and Verification of a New Coronavirus Multiplex Nucleic Acid Detection SystemStatus unknownNCT04311398
- Favipiravir Combined With Tocilizumab in the Treatment of Corona Virus Disease 2019Status unknownNCT04310228Not applicable
- Acute Respiratory Failure and COVID-19 in Real LifeCompletedNCT04307459
- Social Media Use During COVID-19CompletedNCT04305574
- Chloroquine/ Hydroxychloroquine Prevention of Coronavirus Disease (COVID-19) in the Healthcare SettingCompletedNCT04303507Not applicable
- Expanded Access Remdesivir (RDV; GS-5734™)No longer availableNCT04302766
- Medical Masks vs N95 Respirators for COVID-19CompletedNCT04296643Phase 4
- Multicenter Clinical Study on the Efficacy and Safety of Xiyanping Injection in the Treatment of New Coronavirus Infection Pneumonia (General and Severe)Status unknownNCT04295551Not applicable
- Efficacy and Safety of IFN-α2β in the Treatment of Novel Coronavirus PatientsStatus unknownNCT04293887Early Phase 1
- Anti-SARS-CoV-2 Inactivated Convalescent Plasma in the Treatment of COVID-19Status unknownNCT04292340
- Clinical Progressive Characteristics and Treatment Effects of 2019-novel CoronavirusStatus unknownNCT04292327
- Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID19 InfectionWithdrawnNCT04290858Phase 2
- Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Severe Corona Virus Disease 2019 (COVID-19)CompletedNCT04288102Phase 2
- The Clinical Study of Carrimycin on Treatment Patients With COVID-19Status unknownNCT04286503Phase 4
- The Effect of T89 on Improving Oxygen Saturation and Clinical Symptoms in Patients With COVID-19WithdrawnNCT04285190Not applicable
- Humanistic Care in Healthcare Workers in Coronavirus Disease 2019WithdrawnNCT04283838Not applicable
- Humanistic Care in Patients With Coronavirus Disease 2019WithdrawnNCT04283825Not applicable
- Study for Novel Coronavirus Pneumonia (NCP)Status unknownNCT04283396
- A Study to Evaluate the Efficacy and Safety of Pirfenidone With Novel Coronavirus InfectionStatus unknownNCT04282902Phase 3
- A New Screening Strategy for 2019 Novel Coronavirus InfectionStatus unknownNCT04281693Not applicable
- Clinical Outcomes of Patients With COVID19WithdrawnNCT04280913
- Fingolimod in COVID-19WithdrawnNCT04280588Phase 2
- NK Cells Treatment for COVID-19CompletedNCT04280224Phase 1
- Detection of 2019 Novel Coronavirus in Multiple Organ System and Its Relationship With Clinical ManifestationsStatus unknownNCT04279795
- Clinical Features of Suspected and Confirmed Patients of 2019 Novel Coronavirus InfectionStatus unknownNCT04279782
- A Pilot Clinical Study on Inhalation of Mesenchymal Stem Cells Exosomes Treating Severe Novel Coronavirus PneumoniaCompletedNCT04276987Phase 1
- Lopinavir/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV TreatmentCompletedNCT04276688Phase 2
- Bevacizumab in Severe or Critical Patients With COVID-19 PneumoniaCompletedNCT04275414Phase 2
- Xiyanping Injection for the Treatment of New Coronavirus Infected PneumoniaStatus unknownNCT04275388
- Identifying Critically-ill Patients With COVID-19 Who Will Benefit Most From Nutrition Support Therapy: Validation of the NUTRIC Nutritional Risk Assessment ToolStatus unknownNCT04274322
- Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined With Standard Treatment/ Standard Treatment in Patients With Suspected and Mild Novel Coronavirus Pneumonia (COVID-19)Status unknownNCT04273763Not applicable
- Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Severe COVID-19Status unknownNCT04273646Not applicable
- French COVID CohortActive, not recruitingNCT04262921
- Evaluating and Comparing the Safety and Efficiency of ASC09/Ritonavir and Lopinavir/Ritonavir for Novel Coronavirus InfectionTerminatedNCT04261907Not applicable
- Viral Excretion in Contact Subjects at High/Moderate Risk of Coronavirus 2019-nCoV Infection. COVID-19.CompletedNCT04259892
- The Efficacy of Lopinavir Plus Ritonavir and Arbidol Against Novel Coronavirus InfectionCompletedNCT04252885Phase 4
- Development of a Simple, Fast and Portable Recombinase Aided Amplification Assay for 2019-nCoVStatus unknownNCT04245631
- A Clinical Trial to Determine the Safety and Immunogenicity of Healthy Candidate MERS-CoV Vaccine (MERS002)CompletedNCT04170829Phase 1
- Study of Safety and Immunogenicity of BVRS-GamVacStatus unknownNCT04130594Phase 1/2
- Study of Safety and Immunogenicity of BVRS-GamVac-CombiStatus unknownNCT04128059Phase 1/2
- Safety and Immunogenicity of the Candidate Vaccine MVA-MERS-S_DF-1 Against MERSCompletedNCT04119440Phase 1
- Lessening Organ Dysfunction With VITamin CCompletedNCT03680274Phase 3
- Safety and Immunogenicity of a Candidate MERS-CoV Vaccine (MERS001)TerminatedNCT03399578Phase 1
- Inhaled Gaseous Nitric Oxide (gNO) Antimicrobial Treatment of Difficult Bacterial and Viral Lung (COVID-19) InfectionsTerminatedNCT03331445Phase 2
- A Safety, Tolerability, Pharmacokinetics and Immunogenicity Trial of Co-administered MERS-CoV Antibodies REGN3048 and REGN3051CompletedNCT03301090Phase 1
- Seroprevalence of MERS-CoV IgG in Healthcare WorkersCompletedNCT02497885
- Respiratory Virus Hospitalization Study (FLU 003 Plus)CompletedNCT01056185
- SARS Coronavirus Vaccine (SARS-CoV)WithdrawnNCT00533741Phase 1
- SARS Survivor EvaluationsWithdrawnNCT00523276